Correlation Between BioAffinity Technologies and Guardforce

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies and Guardforce at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies and Guardforce into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between bioAffinity Technologies Warrant and Guardforce AI Co, you can compare the effects of market volatilities on BioAffinity Technologies and Guardforce and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies with a short position of Guardforce. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies and Guardforce.

Diversification Opportunities for BioAffinity Technologies and Guardforce

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between BioAffinity and Guardforce is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies Warra and Guardforce AI Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Guardforce AI and BioAffinity Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies Warrant are associated (or correlated) with Guardforce. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Guardforce AI has no effect on the direction of BioAffinity Technologies i.e., BioAffinity Technologies and Guardforce go up and down completely randomly.

Pair Corralation between BioAffinity Technologies and Guardforce

Assuming the 90 days horizon bioAffinity Technologies Warrant is expected to under-perform the Guardforce. But the stock apears to be less risky and, when comparing its historical volatility, bioAffinity Technologies Warrant is 2.17 times less risky than Guardforce. The stock trades about -0.03 of its potential returns per unit of risk. The Guardforce AI Co is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  11.00  in Guardforce AI Co on November 1, 2024 and sell it today you would earn a total of  8.00  from holding Guardforce AI Co or generate 72.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

bioAffinity Technologies Warra  vs.  Guardforce AI Co

 Performance 
       Timeline  
BioAffinity Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days bioAffinity Technologies Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Guardforce AI 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Guardforce AI Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal forward indicators, Guardforce showed solid returns over the last few months and may actually be approaching a breakup point.

BioAffinity Technologies and Guardforce Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioAffinity Technologies and Guardforce

The main advantage of trading using opposite BioAffinity Technologies and Guardforce positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies position performs unexpectedly, Guardforce can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardforce will offset losses from the drop in Guardforce's long position.
The idea behind bioAffinity Technologies Warrant and Guardforce AI Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon